Previous Close | 34.07 |
Open | 34.09 |
Bid | 33.95 x 50000 |
Ask | 35.10 x 50000 |
Day's Range | 34.09 - 34.09 |
52 Week Range | 30.62 - 38.40 |
Volume | |
Avg. Volume | 9 |
Market Cap | 17.48B |
Beta (5Y Monthly) | -0.05 |
PE Ratio (TTM) | 33.10 |
EPS (TTM) | 1.03 |
Earnings Date | Nov 04, 2024 - Nov 08, 2024 |
Forward Dividend & Yield | 0.48 (1.41%) |
Ex-Dividend Date | Sept 27, 2024 |
1y Target Est | N/A |
Today, Ajinomoto Co., Inc. ("Ajinomoto Co.") (TSE: 2802) launched a new version of its StemFit™ iPSC expansion medium. The enhanced version of its widely used StemFit™ products is designed to improve the growth and pluripotency of induced pluripotent stem cells (iPSC) and meet the Good Manufacturing Practice (GMP) standards for Active Pharmaceutical Ingredients (API).
If you want to compound wealth in the stock market, you can do so by buying an index fund. But investors can boost...
Ajinomoto (Malaysia) Berhad ( KLSE:AJI ) Third Quarter 2024 Results Key Financial Results Revenue: RM170.8m (up 17...